Cargando…

Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation

INTRODUCTION: The presence of intraductal prostate cancer in a sample is often associated with large tumor volume, an advanced stage of the disease, a high Gleason score and an increased risk of recurrence, and resistance to androgen suppression and chemotherapy, which are also correlated with reduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faviana, Pinuccia, Belgio, Beatrice, Panichi, Marco, Manassero, Francesca, Selli, Cesare, Boldrini, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197013/ https://www.ncbi.nlm.nih.gov/pubmed/35711477 http://dx.doi.org/10.4103/UA.UA_131_20

Ejemplares similares

Primary small cell carcinoma of the ureter: Case report and review of the literature
por: Farci, Fabiola, et al.
Publicado: (2018)

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?
por: Faviana, Pinuccia, et al.
Publicado: (2021)

Robotically assisted removal of pelvic splenosis fifty-six years after splenectomy: A case report
por: Tognarelli, Alessio, et al.
Publicado: (2021)

Autologous fascial slings remain viable at long-term follow-up: a post cystectomy case report
por: Durante, Jacopo, et al.
Publicado: (2021)

Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database
por: Boldrini, Laura, et al.
Publicado: (2021)

Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis
por: Arcovito, Giorgia, et al.
Publicado: (2020)

Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants?
por: Stanca, Stefano, et al.
Publicado: (2022)

Intraductal carcinoma of the prostate in an Irish prostate cancer patient cohort—an aggressive pathology and a strong familial link
por: Haroon, Usman M., et al.
Publicado: (2020)

Staging of pelvic lymph nodes in patients with prostate cancer: Usefulness of multiple b value SE-EPI diffusion-weighted imaging on a 3.0 T MR system
por: Vallini, Valentina, et al.
Publicado: (2015)

Intraductal carcinoma of the prostate
por: Szentirmai, Eszter, et al.
Publicado: (2020)

Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer
por: Zhu, Sha, et al.
Publicado: (2019)

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
por: Zhu, Sha, et al.
Publicado: (2022)

Prostate Cancer with Intraluminal Inclusions: the Association of the Immunophenotype with Grade Score
por: Pidddubnyi, Artem, et al.
Publicado: (2019)

Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait
por: Pantazopoulos, Helen, et al.
Publicado: (2022)

Intraductal Carcinoma of the Prostate: To Grade or Not to Grade
por: Surintrspanont, Jerasit, et al.
Publicado: (2023)

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients
por: KC, Madhav, et al.
Publicado: (2022)

Association of prostate volume with incidence and aggressiveness of prostate cancer
por: Al-Khalil, Shadi, et al.
Publicado: (2016)

Intraductal Carcinoma of the Prostate Gland: Recent Advances
por: Divatia, Mukul K., et al.
Publicado: (2016)

Evaluation of protein biomarkers of prostate cancer aggressiveness
por: Rizzardi, Anthony E, et al.
Publicado: (2014)

Immunophenotype of Normal and Myelomatous Plasma-Cell Subsets
por: Robillard, Nelly, et al.
Publicado: (2014)

The first Japanese case of intraductal cancer of the prostate with checkpoint kinase 2 mutation
por: Hongo, Hiroshi, et al.
Publicado: (2022)

Testis-sparing surgery for benign and malignant tumors: A critical analysis of the literature
por: Giannarini, Gianluca, et al.
Publicado: (2008)

A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab
por: Tognarelli, Alessio, et al.
Publicado: (2019)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers()
por: Burdelski, Christoph, et al.
Publicado: (2017)

WSB1 Involvement in Prostate Cancer Progression
por: Boldrini, Laura, et al.
Publicado: (2023)

Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review
por: Roberts, Jordan A., et al.
Publicado: (2013)

Intraductal carcinoma of the prostate: a critical re-appraisal
por: Varma, Murali, et al.
Publicado: (2019)

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate
por: Kang, Minyong, et al.
Publicado: (2021)

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study
por: Diop, Mame-Kany, et al.
Publicado: (2023)

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020)

Intravesical migration of female urethral dilator: a case report of a new urologic emergency in the era of e-commerce
por: Mogorovich, Andrea, et al.
Publicado: (2018)

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
por: Böttcher, René, et al.
Publicado: (2018)

Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma
por: Tzelepi, Vasiliki, et al.
Publicado: (2021)

Evolution of ASC Immunophenotypical Subsets During Expansion In Vitro
por: Peng, Qiuyue, et al.
Publicado: (2020)

Reappraisal of the Immunophenotype of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs)—Gastric Pyloric and Small Intestinal Immunophenotype Expression in Gastric and Intestinal Type IPMNs—
por: Kobayashi, Mikiko, et al.
Publicado: (2014)

Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients
por: Xu, Junfeng, et al.
Publicado: (2020)

Blood-Based Biomarkers of Aggressive Prostate Cancer
por: Liong, Men Long, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f0b17nu6ikuel39q2a9j92b5fu